FARON

Welcome to the Brand page for “FARON”, which is offered here for Pharmaceutical research and development; development of pharmaceutical preparations and medicines; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research; all the aforementioned services relating to pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammations and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions, or to pharmaceutical preparations for treatment and prevention of multiorgan failure, acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates, or to medical and veterinary preparations to prevent inflammations and cancer growth and spread, or to pharmaceutical preparations for the treatment of cancer, or to tumor suppressing agents, or to antineoplastics, or to anti-cancer preparations, or to compounds for treating cancer, or to antibodies for medical use to treat inflammation and cancer growth and spread, or to adjuvants for medical purposes, or to vaccine adjuvants;.

Its status is currently believed to be active. Its class is unavailable. “FARON” is believed to be currently owned by “Faron Pharmaceuticals Oy”.